Evidence map›Paper›PMID 34063426›Full record

ArticlePathogens (Basel, Switzerland)2021

Label-Free Comparative Proteomics of Differentially Expressed

Nadeem Ullah, Ling Hao, Jo-Lewis Banga Ndzouboukou, Shiyun Chen, Yaqi Wu, Longmeng Li, Eman Borham Mohamed, Yangbo Hu, Xionglin Fan

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Infection and drug resistance · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Nadeem UllahDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.ORCID 0000-0001-6089-8906
Ling HaoDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Jo-Lewis Banga NdzouboukouDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.ORCID 0000-0003-1501-8361
Shiyun ChenCAS Key Laboratory of Special Pathogens and Biosafety, Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
Yaqi WuDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Longmeng LiDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Eman Borham MohamedDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Yangbo HuCAS Key Laboratory of Special Pathogens and Biosafety, Institute of Virology, Chinese Academy of Sciences, Wuhan 430071, China.
Xionglin FanDepartment of Pathogen Biology, School of Basic Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.ORCID 0000-0001-9754-372X
Huazhong University of Science and Technology · CNChinese Academy of Sciences · CN

Funding

HUST COVID-19 Rapid Response Call 2020kfyXGYJ040National Mega-Projects of Science Research for the 13th Five-year Plan of China 2018ZX10302302002-001Open Research Fund Program of CAS Key Laboratory of Special Pathogens and Biosafety, Chinese Academy of Sciences, the Natural Science Foundation of China 81971909
6 · The paper itself

Abstract

Rifampicin (RIF) is one of the most important first-line anti-tuberculosis (TB) drugs, and more than 90% of RIF-resistant (RR)

Indexed as

drug resistancelabel-freeMycobacterium tuberculosisproteomicsrifampicin

Identifiers

PMID34063426
PMCPMC8157059
OpenAlexW3163283528

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.